Dept of Pathology, University of California San Francisco, San Francisco, CA, USA
Eur Respir Rev. 2018 Feb 28;27(147). doi: 10.1183/16000617.0132-2017. Print 2018 Mar 31.
Classifying pulmonary fibrotic disease into various diagnostic categories provides the clinician with expectations for both prognosis and proper treatment. Despite years of experience with histological, radiological and clinical guidelines, a group of patients remains with unclassifiable interstitial lung disease. In this article, the possible barriers to classification will be explored, and some strategies will be discussed to aid in overcoming these barriers.
将肺纤维化疾病分类为各种诊断类别可为临床医生提供预后和适当治疗的预期。尽管在组织学、影像学和临床指南方面拥有多年经验,但仍有一组患者的间质性肺疾病无法分类。本文将探讨分类可能存在的障碍,并讨论一些策略来帮助克服这些障碍。